The Impact of Lixisenatide on Postprandial Glucose Tolerance in Pancreatectomised Subjects -a Delineation of Extrapancreatic Effects
Phase of Trial: Phase I
Latest Information Update: 13 Jun 2017
At a glance
- Drugs Lixisenatide (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms Px-Lixi
- 13 Jun 2017 Results presented at the 77th Annual Scientific Sessions of the American Diabetes Association.
- 24 Oct 2016 Status changed from recruiting to completed.
- 11 Jan 2016 New trial record